Xcout IntelAmplicore Inc.
Amplicore Inc. develops injectable therapeutics aimed at treating degenerative musculoskeletal disorders such as osteoarthritis, cartilage damage, degenerative disc disease, and acute meniscus tears. The company focuses on regenerative and minimally invasive approaches to address the underlying causes of joint discomfort and restore mobility for patients.
Subscribe to see Amplicore Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Amplicore Inc. at a glance
Amplicore Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Grant, raised $5M in March 2021. Xcout tracks 8 named people at Amplicore Inc., including Felix Chang (General Counsel VP of Finance & Administration).
Amplicore Inc. leadership
- Felix ChangGeneral Counsel VP of Finance & Administration
- C. James LinFounder President & Chief Executive Officer
- James HambySenior Vice President of Business Development
- Tina ChenDirector of Clinical Affairs Pharmaceutical Project Manager
- Tyler VandivortDirector of Regulatory Affairs and Operations
- Amalia TollasAdministrative Coordinator
2 more named people on record for Amplicore Inc., with roles, board committees and tenure — see the full roster →
Amplicore Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Grant | $5M | 9 named | |
| Seed | $4M | 3 named | |
| SEC Form D filing | $2.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Amplicore Inc. competitors
A few of Amplicore Inc.'s closest competitors — see the full list of competitors and alternatives →
SpinalCyte is a U.S. biotechnology company developing regenerative, cell-based therapies for spinal disorders, particularly degenerative disc disease. Its work has focused on injectable allogeneic cell therapies intended to repair or regenerate damaged intervertebral discs, serving patients with spinal degeneration.
Regentis Biomaterials Ltd. is a regenerative medicine firm dedicated to crafting innovative solutions for tissue repair, ultimately aiming to enhance patients' health and overall quality of life. The company's primary product in development is GelrinC, a novel, cell-free, ready-to-use hydrogel designed to be solidified into an implant within the knee. This implant serves to address painful knee injuries and mend articular cartilage damage. Regentis Biomaterials leverages its proprietary Gelrin platform, which employs biodegradable hydrogel implants, to develop orthopedic therapies that facilitate the regeneration of compromised or diseased tissues. The company was established in 2004 and operates from its headquarters in Herzliya, Israel.
Biosplice Therapeutics, Inc., formerly known as Samumed, LLC, is a private biopharmaceutical company based in San Diego, California. The company focuses on clinical developments such as pivotal trials for knee osteoarthritis.
Tavra Biosciences supplies cGMP-manufactured stem cell biologics, specifically bone marrow-derived mesenchymal stem cells, to licensed physicians for localized clinical use in orthopedic and regenerative medicine. The company's off-the-shelf products are manufactured in a compliant cleanroom facility and provided to support clinical practices in sports medicine and pain management.
Amplica Bio, Inc. is a biotechnology company that develops next-generation biologics and therapies aimed at targeting difficult diseases. The company engages in drug engineering to address challenging therapeutic targets.
Get Amplicore Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Amplicore Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access